
    
      A Randomized, Multi-Center, Open-Label Study To Evaluate The Efficacy And Safety Of Albuferon
      (HGS 1008, Recombinant Human Albumin-Interferon Alfa Fusion Protein) In Combination With
      Ribavirin In Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 OR 3
    
  